Same Indication

Methotrexate vs Palivizumab

Methotrexate vs Palivizumab: Overview

This comparison examines the pharmacological differences between Methotrexate and Palivizumab.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5.

Molecular Weight: Methotrexate — 454.4400 g/mol.

Type: Methotrexate — Small molecule; Palivizumab — Antibody.